{"id":1961,"date":"2026-04-22T11:13:00","date_gmt":"2026-04-22T08:13:00","guid":{"rendered":"https:\/\/en.tomanifesto.gr\/?p=1961"},"modified":"2026-04-22T11:13:00","modified_gmt":"2026-04-22T08:13:00","slug":"adonis-georgiades-in-the-economist-the-patient-is-at-the-centre-of-cancer-policies","status":"publish","type":"post","link":"https:\/\/en.tomanifesto.gr\/?p=1961","title":{"rendered":"Adonis Georgiades in The Economist: the patient is at the centre of cancer policies"},"content":{"rendered":"<p>Treating <b>cancer <\/b>is one of the most important priorities <b>of <b><a href=\"https:\/\/tomanifesto.gr\/dimosio\" target=\"_blank\" rel=\"noopener\">public health <\/b>both at European and national level.<\/p>\n<p>The <b>EU<\/b> has developed a comprehensive policy framework, with the &#8220;European Plan to Combat Cancer<\/b>&#8221; as its central pillar. This plan aims at a comprehensive <b>treatment of the disease<\/b>, covering all stages: prevention, early diagnosis, treatment and improvement of the quality of life of patients and survivors, while placing particular emphasis on reducing inequalities between Member States.<\/p>\n<p>Greece, as a<b> EU member state,<\/b> is integrating European guidelines into its national policies, actively participating in joint actions and programmes, speakers at the sixth annual<b> Summit<\/b>on cancer in Greece, entitled &#8220;Fighting cancer in turbulent times&#8221;, organised by The Economist.<\/p>\n<p>During his speech at the conference, Health Minister Adonis Georgiades,<\/b> said that a new system is currently under public consultation that will allow for faster entry of <b>innovative<\/b><b>pharmaceuticals <\/b>in Greece.<\/p>\n<p>He stressed the importance of the state&#8217;s cooperation with all stakeholders in order to achieve a balance between <b>innovation <\/b>and budgetary constraints. He stressed that the government&#8217;s policy is aimed at supporting patients, and national plans are already in place to address cancer.<\/p>\n<p>As regards the challenges of the <b>last 15 years<\/b>, he noted that trust has been built with both the medical community and patients, and pointed out that although much remains to be done, the country is on the right track.<\/p>\n<p>The minister also touched on <b>pharmaceutical policy<\/b>, noting that the US market, as the world&#8217;s largest, inevitably influences developments at the international level. As he pointed out, when something important happens in the <b>United States<\/b>, it is impossible not to have an impact on other markets, with a key issue being the supply of medicines to countries.<\/p>\n<p>Special emphasis was placed on the <b>concept of price alignment<\/b>, which, if implemented, could bring about radical changes in the global pharmaceutical landscape. However, he stressed that this transition would not be easy and would be accompanied by challenges.<\/p>\n<p>In response to these developments, he highlighted the importance of greater integration, expressing confidence that the European Union can play a key role. He noted that, as a whole, the <b>European Union<\/b> is on a par with the United States in terms of power and assessed that international changes will necessarily lead to greater policy alignment within the EU.<\/p>\n<p>Emmanuel Saloustros<\/b> &#8211; Associate Professor of Medicine, University of Thessaly \/ Chairman of the Board, Hellenic Society of Pathological Oncology, highlighted the main priorities for the progress of the system:<\/p>\n<p>&#8211; Training of physicians and strengthening of human resources<\/p>\n<p>&#8211; Equal access of patients to health services and improvement of the predictability of the system<\/p>\n<p>&#8211; Ensuring sustainability through appropriate policies<\/p>\n<p>&#8211; Focus on prevention and data collection for policy making<\/p>\n<p>&#8211; Strengthening clinical research<\/p>\n<p>&#8211; Promoting sustainability and &#8220;green oncology&#8221;<\/p>\n<p>&#8211; Need to strengthen palliative care<\/p>\n<p>He stressed that <b>Greece<\/b>has the necessary scientific potential to achieve these goals and that the cooperation of all stakeholders is crucial.<\/p>\n<p>For his part, <b>Giorgos Kapetanakis<\/b> &#8211; president of the <b>Greek Cancer Federation<\/b>, pointed out that while oncology is in a period of significant developments, patients do not always directly experience the benefits of these changes.<\/p>\n<p><b>He referred to critical issues such as:<\/b><\/p>\n<p>&#8211; Creation and utilization of patient registries<\/p>\n<p>&#8211; Digital transformation of oncology care<\/p>\n<p>&#8211; Home delivery of high-cost drugs<\/p>\n<p>&#8211; Biomarker reimbursement<\/p>\n<p>He raised the key question of whether the <b>health system<\/b>can support these changes, emphasizing that the reforms need to reach patients in a meaningful way.<\/p>\n<p>He also stressed that a more holistic approach to <b>oncology care<\/b> is taking shape, with a focus on quality of life. Patient associations say they are ready to contribute to the formulation of the national cancer action plan.<\/p>\n<p><b>Mr. Kapetanakis concluded that three key issues:<\/b><\/p>\n<p>&#8211; Access to innovation<\/p>\n<p>&#8211; Integration of patient experience<\/p>\n<p>&#8211; Strengthening collaboration as a key prerequisite for progress<\/p>\n<p>Finally, <b>Cyril Skiver<\/b> &#8211; Regional President, Mid-European Federation, MSD, stressed that dialogue and collaboration between stakeholders is a sign of progress towards a more patient-centred health system.<\/p>\n<p>He stressed the importance of clinical research, noting that there are currently around <b>80 studies being conducted in Greece<\/b>, the result of collaboration between all stakeholders.<\/p>\n<p>He noted that the next step is to strengthen <b>patient registries<\/b> to evaluate what works and what doesn&#8217;t, and to better align interventions. He concluded that the focus should be on patients and that Greece has already made significant progress.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Treating cancer is now one of the most important public health priorities at both European and national level.<\/p>\n","protected":false},"author":1,"featured_media":1962,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-1961","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-politics"],"acf":[],"_links":{"self":[{"href":"https:\/\/en.tomanifesto.gr\/index.php?rest_route=\/wp\/v2\/posts\/1961","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/en.tomanifesto.gr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/en.tomanifesto.gr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/en.tomanifesto.gr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/en.tomanifesto.gr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1961"}],"version-history":[{"count":0,"href":"https:\/\/en.tomanifesto.gr\/index.php?rest_route=\/wp\/v2\/posts\/1961\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/en.tomanifesto.gr\/index.php?rest_route=\/wp\/v2\/media\/1962"}],"wp:attachment":[{"href":"https:\/\/en.tomanifesto.gr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1961"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/en.tomanifesto.gr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1961"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/en.tomanifesto.gr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1961"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}